Literature DB >> 2762218

Racial differences in drug response: isoproterenol effects on heart rate in healthy males.

D R Rutledge1, L Cardozo, J D Steinberg.   

Abstract

It was the purpose of this study to investigate racial alterations in beta-adrenoceptor response. Two groups of healthy, male volunteers gave their consent. There were eight black Americans (mean age, 26.1 +/- 2.5 years) and eight white/Caucasian Americans (mean age 24.4 +/- 1.8 years). Each subject underwent an isoproterenol sensitivity test. There was a significant (P less than 0.05) decrease in the ratio of Emax to ED50 in the white group (25.3 +/- 6.4) compared with the black group (37.1 +/- 12.4). Over the dose range of 0.1 to 1.0 micrograms there was a significant increase in response at both the 0.25- and the 0.5-microgram dose (P less than 0.05), with the black American group appearing to respond with a greater rate of rise in heart rate following the initial doses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762218     DOI: 10.1023/a:1015996929574

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  THE EYE OF THE WEST AFRICAN NEGRO.

Authors:  J G Scott
Journal:  Br J Ophthalmol       Date:  1945-01       Impact factor: 4.638

2.  Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975.

Authors:  J Stamler; R Stamler; W F Riedlinger; G Algera; R H Roberts
Journal:  JAMA       Date:  1976-05-24       Impact factor: 56.272

Review 3.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects.

Authors:  W Frishman; R Silverman
Journal:  Am Heart J       Date:  1979-06       Impact factor: 4.749

4.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

Review 5.  Nadolol: a new beta-adrenoceptor antagonist.

Authors:  W H Frishman
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Vagal activity is increased during intravenous isoprenaline infusion in man.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 8.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

Review 9.  Pharmacokinetic and pharmacodynamic modeling in vivo.

Authors:  N H Holford; L B Sheiner
Journal:  Crit Rev Bioeng       Date:  1981

10.  Trial of atenolol and chlorthalidone for hypertension in black South Africans.

Authors:  Y K Seedat
Journal:  Br Med J       Date:  1980-11-08
View more
  2 in total

1.  Racial differences in drug response: isoproterenol effects before and after propranolol.

Authors:  D R Rutledge; A Wallace; J D Steinberg; L Cardozo; S J Lavine
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.